Artiva Biotherapeutics, Inc.
ARTV
$10.79
-$0.09-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.01M | -23.52M | -20.77M | -21.53M | -21.25M |
| Total Depreciation and Amortization | 692.00K | 666.00K | 666.00K | 662.00K | 641.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 1.39M | 1.30M | 1.27M | 1.04M |
| Change in Net Operating Assets | 2.21M | 506.00K | 4.08M | 391.00K | -3.41M |
| Cash from Operations | -20.36M | -20.95M | -14.73M | -19.20M | -22.98M |
| Capital Expenditure | -415.00K | -242.00K | -421.00K | -600.00K | -1.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.00M | 15.56M | 16.46M | 16.88M | 22.18M |
| Cash from Investing | 17.59M | 15.32M | 16.04M | 16.28M | 21.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.00K | -33.00K | -34.00K | -32.00K | -33.00K |
| Issuance of Common Stock | 300.21M | -- | 0.00 | -- | 134.00K |
| Repurchase of Common Stock | 0.00 | -210.00K | -87.00K | -238.00K | -39.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.92M | 131.00K | 0.00 | 233.00K | -134.00K |
| Cash from Financing | 283.27M | -112.00K | -121.00K | -37.00K | -72.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 280.50M | -5.75M | 1.19M | -2.96M | -1.93M |